Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.
Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution
Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV.
Autorzy:
Burke-Miller JK; a Hektoen Institute of Medicine , Chicago , IL , USA. Weber K; a Hektoen Institute of Medicine , Chicago , IL , USA.; b Ruth M. Rothstein CORE Center, Cook County Health and Hospitals System , Chicago , IL , USA. Cohn SE; c Feinberg School of Medicine , Northwestern University , Chicago , IL , USA. Hershow RC; d University of Illinois at Chicago School of Public Health , Chicago , IL , USA. Sha BE; e Rush University Medical Center , Chicago , IL , USA. French AL; b Ruth M. Rothstein CORE Center, Cook County Health and Hospitals System , Chicago , IL , USA.; e Rush University Medical Center , Chicago , IL , USA. Cohen MH; e Rush University Medical Center , Chicago , IL , USA.; f Stroger Hospital, Cook County Health and Hospitals System , Chicago , IL , USA.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2016 Oct; Vol. 28 (10), pp. 1274-9. Date of Electronic Publication: 2016 Apr 21.
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
"You Come Back to the Same Ole Shit:" A Qualitative Study of Smoking Cessation Barriers among Women Living with HIV: Implications for Intervention Development.
Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection.
Virdi AK; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America. Wallace J; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America. Barbian H; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America. Richards MH; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America. Ritz EM; Biostatistics and Bioinformatics Core, Rush University Medical Center, Chicago, IL, United States of America. Sha B; Infectious Diseases Division, Rush Medical College, Chicago, IL, United States of America. Al-Harthi L; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Sep 22; Vol. 15 (9), pp. e0239157. Date of Electronic Publication: 2020 Sep 22 (Print Publication: 2020).
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
